The CDC has spoken on opioid scripts: Use fewer of them

The Centers for Disease Control and Prevention (CDC) has rolled out new guidelines for prescribing opioids, a move the agency hopes can help reduce the rate of addiction in the U.S. to the powerful painkillers, but which will also have the effect of further dampening sales of the drugs. More from FiercePharma

Suggested Articles

In previously untreated nonsquamous NSCLC, a Tyvyt-chemo combo beat chemo alone at stalling the time to tumor progression or death.

Roche’s Tecentriq didn't repeat its prior TNBC success when tested in tandem with chemo med paclitaxel in previously untreated metastatic patients.

Alexion Pharmaceuticals names its first chief diversity officer as the rare disease specialist looks to cultivate diversity and inclusion.